BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totalling 1,100 shares, a drop of 42.1% from the September 30th total of 1,900 shares. Based on an average daily trading volume, of 3,900 shares, the days-to-cover ratio is presently 0.3 days.
BioSyent Price Performance
OTCMKTS BIOYF opened at $8.21 on Friday. The stock’s fifty day moving average is $7.92 and its two-hundred day moving average is $7.25. BioSyent has a fifty-two week low of $5.65 and a fifty-two week high of $8.90.
BioSyent Increases Dividend
The firm also recently declared a dividend, which was paid on Sunday, September 15th. Investors of record on Thursday, September 5th were issued a $0.0334 dividend. This is a boost from BioSyent’s previous dividend of $0.03. The ex-dividend date was Wednesday, September 4th. This represents a yield of 1.72%.
BioSyent Company Profile
BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.
Featured Stories
- Five stocks we like better than BioSyent
- Bank Stocks – Best Bank Stocks to Invest In
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- About the Markup Calculator
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.